Urinary tract infections are among the most common types of illnesses among all ages.
However, in some instances, a lack of accurate and efficient diagnostics has led to UTIs being misdiagnosed or inappropriately treated.
Conventional laboratory culture techniques can take 3-7 days to return. These techniques may be limited in that they only detect the most common pathogens like E coli; yet, there are numerous other pathogens that cause UTIs. These are usually missed because they don’t easily grow in a culture medium.
Clinicians have often been left with no choice but to prescribe broad-spectrum antibiotics while awaiting test results. Unfortunately, this has contributed to the growing epidemic of antibiotic resistance.
Clinical Solution
Vikor Scientific™ offers the clinician access to the most advanced molecular methodology for pathogen detection, quantification, and resistance gene identification. Vikor delivers rapid and precise results simultaneously through a value-based technology platform, ABXAssist™, which incorporates regional sensitivity and susceptibility patterns, medication costs, antibiotic spectrum of activity, and FDA guidance.
The end product is a patient-centered, value-based care solution that enables providers to make informed treatment decisions that could avoid inappropriate therapy, excess costs, adverse drug events and the progression of disease.
Clinical Advantages
- Prevents delays in diagnosis and treatment (*results within 24 to 48 hours post specimen arrival to lab)
- Detects polymicrobial infections simultaneously
- Identifies up to 49 antibiotic resistance genes in 12 antibiotic categories including Methicillin, Carbapenem and Vancomycin resistance
- Markedly less susceptible to being affected by concurrent antibiotic therapy
- Reduces unnecessary drug exposure and adverse events
- Decreases the progression and spread of infection
- Provides up-to-date regional sensitivity and susceptibility patterns
- Improves selection of narrow-spectrum antibiotics
- Prepares clinicians to make cost-effective treatment decisions
- Easily accessible results (mobile, web-portal or EMR integration)
* Test results could be delayed in some circumstances when there is error in clerical documentation, collections, lab handling, or a delay in shipping.
